AU768118B2 - Chemical synthesis and use of soluble membrane protein receptor domains - Google Patents
Chemical synthesis and use of soluble membrane protein receptor domains Download PDFInfo
- Publication number
- AU768118B2 AU768118B2 AU38748/00A AU3874800A AU768118B2 AU 768118 B2 AU768118 B2 AU 768118B2 AU 38748/00 A AU38748/00 A AU 38748/00A AU 3874800 A AU3874800 A AU 3874800A AU 768118 B2 AU768118 B2 AU 768118B2
- Authority
- AU
- Australia
- Prior art keywords
- receptor
- extramembranous
- domain
- ligand
- ligation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/13—Labelling of peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12427299P | 1999-03-11 | 1999-03-11 | |
US60/124272 | 1999-03-11 | ||
PCT/US2000/006297 WO2000053624A1 (fr) | 1999-03-11 | 2000-03-09 | Synthese chimique et utilisation de domaines de recepteurs de proteines membranaires solubles |
Publications (2)
Publication Number | Publication Date |
---|---|
AU3874800A AU3874800A (en) | 2000-09-28 |
AU768118B2 true AU768118B2 (en) | 2003-12-04 |
Family
ID=22413849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU38748/00A Ceased AU768118B2 (en) | 1999-03-11 | 2000-03-09 | Chemical synthesis and use of soluble membrane protein receptor domains |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1159289A1 (fr) |
JP (1) | JP2002539136A (fr) |
CN (1) | CN1350544A (fr) |
AU (1) | AU768118B2 (fr) |
CA (1) | CA2372164A1 (fr) |
HK (1) | HK1046534A1 (fr) |
WO (1) | WO2000053624A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7482425B2 (en) | 1999-08-26 | 2009-01-27 | Amylin Pharmaceuticals, Inc. | Compositions for lipid matrix-assisted chemical ligation |
US6784291B2 (en) | 2000-05-04 | 2004-08-31 | Avi Biopharma, Inc. | Splice-region antisense composition and method |
US8618054B2 (en) | 2004-05-05 | 2013-12-31 | Valorisation-Rechereche Société en Commandite | Interleukin-1 receptor antagonists, compositions, and methods of treatment |
JP2008542685A (ja) * | 2005-05-05 | 2008-11-27 | ヴァロリザーシヨン・アッシュエスジ,ソシエテ・アン・コマンディット | サイトカイン受容体修飾因子及びその使用 |
US7785834B2 (en) | 2005-11-10 | 2010-08-31 | Ercole Biotech, Inc. | Soluble TNF receptors and their use in treatment of disease |
AU2007309650A1 (en) * | 2006-02-08 | 2008-05-02 | Ercole Biotech, Inc. | Soluble TNF receptors and their use in treatment of disease |
WO2012116203A1 (fr) * | 2011-02-23 | 2012-08-30 | Massachusetts Institute Of Technology | Protéines membranaires hydrosolubles et leurs procédés de préparation et d'utilisation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995003321A1 (fr) * | 1993-07-20 | 1995-02-02 | Bionebraska, Inc. | Procede d'endomodification de proteins |
EP1001968B1 (fr) * | 1997-06-13 | 2004-12-22 | Gryphon Therapeutics, Inc. | Ligation chimique native en phase solide de peptides non proteges ou proteges en cysteine n-terminale dans une solution aqueuse |
-
2000
- 2000-03-09 WO PCT/US2000/006297 patent/WO2000053624A1/fr active IP Right Grant
- 2000-03-09 CA CA002372164A patent/CA2372164A1/fr not_active Abandoned
- 2000-03-09 EP EP00917838A patent/EP1159289A1/fr not_active Withdrawn
- 2000-03-09 AU AU38748/00A patent/AU768118B2/en not_active Ceased
- 2000-03-09 JP JP2000604059A patent/JP2002539136A/ja active Pending
- 2000-03-09 CN CN00807439A patent/CN1350544A/zh active Pending
-
2002
- 2002-11-12 HK HK02108186.5A patent/HK1046534A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
AU3874800A (en) | 2000-09-28 |
CA2372164A1 (fr) | 2000-09-14 |
CN1350544A (zh) | 2002-05-22 |
JP2002539136A (ja) | 2002-11-19 |
HK1046534A1 (zh) | 2003-01-17 |
EP1159289A1 (fr) | 2001-12-05 |
WO2000053624A1 (fr) | 2000-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sewald et al. | Peptides: chemistry and biology | |
US6451543B1 (en) | Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides | |
US11142550B2 (en) | Split inteins with exceptional splicing activity | |
Liu et al. | Chemical synthesis of peptides within the insulin superfamily | |
Karas et al. | The chemical synthesis of insulin: an enduring challenge | |
Wu et al. | Synthesis of four-disulfide insulin analogs via sequential disulfide bond formation | |
Bao et al. | Highly efficient expression and purification system of small-size protein domains in Escherichia coli for biochemical characterization | |
AU768118B2 (en) | Chemical synthesis and use of soluble membrane protein receptor domains | |
Wang et al. | Chemical Synthesis of diSUMO Photoaffinity Probes for the Identification of PolySUMO Chain-Specific Interacting Proteins | |
Thalluri et al. | Synthesis of disulfide-rich heterodimeric peptides through an auxiliary N, N-crosslink | |
US7482425B2 (en) | Compositions for lipid matrix-assisted chemical ligation | |
Umanah et al. | Cross-linking of a DOPA-containing peptide ligand into its G protein-coupled receptor | |
Tang et al. | Human gene 2 relaxin chain combination and folding | |
Zaykov et al. | High-yield synthesis of human insulin-like peptide 5 employing a nonconventional strategy | |
Zou et al. | Biosynthesis and NMR-studies of a double transmembrane domain from the Y4 receptor, a human GPCR | |
US20130143251A1 (en) | Expeditious synthesis of ubiquitinated peptide conjugates | |
Gordon et al. | Total chemical synthesis of fully functional Photoactive Yellow Protein | |
EP3888667A1 (fr) | Analogues du glucagon et leurs procédés d'utilisation | |
Zoukimian et al. | 2-Hydroxy-4-methoxybenzyl as a Thiol-Protecting Group for Directed-Disulfide Bond Formation | |
Banerjee et al. | Expression of functional scorpion neurotoxin Lqq-V in E. coli | |
Büllesbach et al. | Synthetic cross-links arrest the C-terminal region of the relaxin-like factor in an active conformation | |
Dong et al. | Design and Synthesis of Cross-Link-Dense Peptides by Manipulating Regioselective Bisthioether Cross-Linking and Orthogonal Disulfide Pairing | |
Grygiel et al. | Synthesis by native chemical ligation and crystal structure of human CCL2 | |
Kocherla et al. | Biosynthesis and spectroscopic characterization of 2‐TM fragments encompassing the sequence of a human GPCR, the Y4 receptor | |
Praveen et al. | Effects of C-terminal B-chain modifications in a relaxin 3 agonist analogue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |